Toll-like receptor signaling in the pathogenesis and prevention of prematurity
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
批准号:
7528461
负责人:
EMMET HIRSCH
金额:
$32.41万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2013-06-30
关键词:
Adaptor Signaling ProteinAffectBindingBirthCell WallCellsCessation of lifeChimeric ProteinsDeveloped CountriesDeveloping CountriesDissectionDoseElementsEmbryo TransferEndometriumEnzymesEscherichia coliFetal MembranesFetusFlagellinGene ExpressionGenesGenotypeGram-Positive BacteriaImmune responseImmune systemIn VitroInbred MouseIncidenceInduced LaborInfectionInflammationInflammatoryInterferonsKnock-outKnowledgeLeukocytesLigandsLinkLipopolysaccharidesMaintenanceMaternal-Fetal ExchangeMeasuresMediator of activation proteinMethodsMolecular ProfilingMothersMusMutant Strains MiceMyelogenousNamesNeonatalNumbersOrganismPathogenesisPathway interactionsPattern RecognitionPeptidesPeptidoglycanPhenotypePlacentaPlayPredispositionPregnancyPremature BirthPremature LaborPrematurity of fetusPreventionProteinsPublic HealthRNA SplicingRangeRateReceptor ActivationReceptor SignalingReporterResistanceRoleSepsisSignal PathwaySignal TransductionSignal Transduction PathwaySpecificityStreptococcusSynthetic ProstaglandinsTLR2 geneTestingTissuesToll-Like Receptor 2Toll-Like Receptor PathwayToll-like receptorsVariantViralWhole OrganismWild Type Mouseabstractingacquired immunitybeta-Galactosidasecytokinefetalhuman TLR3 proteinin vivomicroorganismmigrationmouse modelmyometriumnovelpathogenpreventresearch studyresponsetoll-like receptor 4
中文摘要
描述(由申请人提供):先天免疫系统通过微生物的分子成分与宿主细胞上称为toll样受体(TLR)的专门模式识别分子的相互作用识别病原体。12种已知的toll样受体中的每一种都与一组不同的病原性标记物结合,从而总共识别大量的微生物。这种参与仅通过两种主要的细胞内途径(称为髓样分化因子88(MyD88)依赖性和MyD88非依赖性信号传导途径)激活和诱导炎症介质。本提案的目的是检验这一假设,即通过MyD88依赖性信号转导通路的Toll样受体信号传导是病原体诱导的早产的必要和可修饰的介导物。该假设将在小鼠模型中进行测试,首先(具体目标#1)使用肽聚糖(衍生自革兰氏阳性细菌细胞壁的TLR-2配体)和B组β-溶血性链球菌(GBBS,与早产和新生儿败血症相关的革兰氏阳性生物体)表征MyD 88依赖性和非依赖性途径在病原体诱导的分娩中的作用。缺乏TLR-2或MyD88的突变小鼠将用于确定这些蛋白质在病原体诱导的分娩中的作用。在具体目标#2中,将测试MyD88的负调节物(称为MyD88s的剪接变体)预防MyD88依赖性早产的能力。一种新的细胞内递送外源蛋白(TAT融合蛋白)的方法将用于将MyD88运送到妊娠区室。最后,在具体目标#3中,我们将利用自首次提交本申请以来的新观察,即E。大肠杆菌诱导的分娩对MyD88有排他性的要求。剖析了母体和胎儿在E.大肠杆菌诱导分娩将使用母体和胎儿MyD88基因型以信息方式不同的妊娠进行。公共卫生相关性:早产影响了美国12%以上的分娩,每年约有480 000名婴儿感染艾滋病毒/艾滋病,这仍然是发达国家新生儿疾病和死亡的最重要原因。50%或更多原因不明的早产病例与感染有关。在美国,早产的发生率持续上升,这一事实反映了我们对分娩的原因和机制的认识仍然存在不足。
英文摘要
DESCRIPTION (provided by applicant): The innate immune system recognizes pathogens via the interaction of molecular constituents of microorganisms with specialized pattern recognition molecules on host cells known as toll-like receptors (TLRs). Each of the 12 known toll-like receptors engages a different set of pathogenic markers, thereby recognizing in total a large variety of microorganisms. This engagement leads to activation and induction of inflammatory mediators via only two major intracellular pathways, known as the myeloid differentiation factor 88 (MyD88)-dependent and MyD88-independent signaling pathways. The objective of this proposal is to test the hypothesis that toll-like receptor signaling via the MyD88-dependent signal transduction pathway is an essential and modifiable mediator of pathogen-induced preterm labor. This hypothesis will be tested in a mouse model by first (Specific Aim #1) characterizing the roles of the MyD88-dependent and -independent pathways in pathogen-induced labor using peptidoglycan (a TLR-2 ligand derived from Gram positive bacterial cell walls) and group B beta-hemolytic streptococcus (GBBS, a Gram positive organism associated with preterm labor and neonatal sepsis). Mutant mice lacking either TLR-2 or MyD88 will be used to define the roles of these proteins in pathogen-induced labor. In Specific Aim #2 the capacity of a negative regulator of MyD88 (a splice variant known as MyD88s) to prevent MyD88-dependent preterm birth will be tested. A new method of delivering exogenous proteins intracellularly (TAT-fusion proteins) will be used to ferry MyD88s into the gestational compartment. Finally, in Specific Aim #3 we will take advantage of a novel observation made since the first submission of this application, namely that E. coli-induced labor has an exclusive requirement for MyD88. Dissection of the respective roles of mothers and fetuses in signaling for E. coli induced labor will be conducted using pregnancies in which maternal and fetal MyD88 genotypes differ in informative ways. PUBLIC HEALTH RELEVANCE: Preterm birth affects over 12% of all deliveries in the U.S., or approximately 480,000 babies annually, and continues to be the most important cause of neonatal illness and death in developed countries. Fifty percent or more of unexplained cases of preterm birth are related to infection. The incidence of preterm delivery continues to rise in the U.S., a fact that reflects continuing deficiencies in our knowledge of the causes and mechanisms of parturition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
-
批准号:10403521
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2019
-
负责人:EMMET HIRSCH
-
依托单位:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
-
批准号:9913576
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2019
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8113517
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2010
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8306264
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:7900346
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:7693765
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
Toll-like receptor signaling in the pathogenesis and prevention of prematurity
-
批准号:8097306
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2008
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6929305
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6776475
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6654496
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
The Molecular Pathogenesis of Health Disparities in Inf*
-
批准号:6526935
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
PATHOGENESIS OF HEALTH DISPARITIES IN PRETERM BIRTH
-
批准号:6437197
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2001
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2330256
-
项目类别:
-
资助金额:$9.68万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057177
-
项目类别:
-
资助金额:$9.52万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:3085492
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057178
-
项目类别:
-
资助金额:$9.59万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
INTERLEUKIN-1 RECEPTOR ANTAGONIST IN MICE
-
批准号:2057176
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1993
-
负责人:EMMET HIRSCH
-
依托单位:
海外基金